We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
+$103K
Cap. Flow
-$916M
Cap. Flow %
-4.16%
Top 10 Hldgs %
10.55%
Holding
2,302
New
567
Increased
501
Reduced
537
Closed
688

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$168M
2
CNP icon
CenterPoint Energy
CNP
+$151M
3
NFLX icon
Netflix
NFLX
+$132M
4
EFX icon
Equifax
EFX
+$132M
5
SRE icon
Sempra
SRE
+$122M

Sector Composition

Rank Sector Weight
1 Financials 14.98%
2 Technology 10.51%
3 Consumer Discretionary 10.34%
4 Industrials 8.24%
5 Healthcare 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSKE
2126
DELISTED
Daseke, Inc. Common Stock
DSKE
-15,789
Closed -$157K
PACW
2127
DELISTED
PacWest Bancorp
PACW
-43,149
Closed -$2.13M
HT
2128
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
-22,776
Closed -$489K
VMW
2129
DELISTED
VMware, Inc
VMW
-321,662
Closed -$47.3M
AVID
2130
DELISTED
Avid Technology Inc
AVID
-43,549
Closed -$226K
LTRPA
2131
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-23,482
Closed -$378K
NATI
2132
PUT
DELISTED
National Instruments Corp
NATI
-50,000
Closed -$2.1M
PRTK
2133
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-15,800
Closed -$161K
QUOT
2134
DELISTED
Quotient Technology Inc
QUOT
-355,140
Closed -$4.65M
ACGN
2135
DELISTED
Aceragen Inc
ACGN
-626
Closed -$112K
AMRS
2136
DELISTED
Amyris Inc.
AMRS
-11,888
Closed -$76K
SPPI
2137
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-335,028
Closed -$7.25M
ROCC
2138
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
-8,227
Closed -$698K
CS
2139
DELISTED
Credit Suisse Group
CS
-23,796
Closed -$354K
KBAL
2140
DELISTED
Kimball International
KBAL
-13,569
Closed -$219K
JNCE
2141
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-28,920
Closed -$222K
MAXR
2142
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-5,715
Closed -$289K
LCI
2143
DELISTED
Lannett Company, Inc.
LCI
-7,341
Closed -$399K
STOR
2144
DELISTED
STORE Capital Corporation
STOR
-79,536
Closed -$2.18M
TCDA
2145
DELISTED
Tricida, Inc. Common Stock
TCDA
-17,250
Closed -$516K
TTM
2146
DELISTED
Tata Motors Limited
TTM
-12,011
Closed -$235K
PRTY
2147
DELISTED
Party City Holdco Inc.
PRTY
-65,002
Closed -$991K
RSX
2148
PUT
DELISTED
VanEck Russia ETF
RSX
-100,000
Closed -$2.12M
OTIC
2149
DELISTED
Otonomy, Inc.
OTIC
-115,747
Closed -$446K
ABMD
2150
DELISTED
Abiomed Inc
ABMD
-2,387
Closed -$976K

Similar funds

Balyasny Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Balyasny Asset Management held 2,302 positions worth $22B, up 0% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management withdrew a net $916M in Q3 2018, closing 688 positions and reducing 537 holdings. Its most notable exit was DuPont de Nemours, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Balyasny Asset Management opened a new position in Equifax worth $132M.

  • Balyasny Asset Management's largest Q3 2018 buy was Equifax: 1,013,016 shares worth $132M.
  • Balyasny Asset Management added most to Walt Disney in Q3 2018, an estimated $168M increase.
  • Balyasny Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $335M.
  • Balyasny Asset Management fully exited DuPont de Nemours in Q3 2018, selling an estimated $144M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q3 2018.
  • Balyasny Asset Management opened 567 new positions and closed 688 in Q3 2018.
  • Balyasny Asset Management's portfolio value rose 0% quarter-over-quarter to $22B.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.